성장을 멈추지 마세요

체험은 만족하셨나요?

현재 45,766명이 마이메르시로 공부 중이에요

지식 자료를 소장하고 멋진 의료인으로 성장하세요

학습 자료 둘러보기 →
Tocolytics | 마이메르시 MyMerci
제안하기

뭔가 하고 싶은 말이 있는거야?

0 / 2000
컨텐츠 수정하기

컨텐츠 내용을 수정할 수 있습니다

수정하기
닫기

Tocolytics

NCLEX Review Guide: Tocolytics in Maternity Care

Understanding Tocolytics

Definition and Purpose

  • Tocolytics are medications administered to inhibit uterine contractions and delay preterm labor. These agents are primarily used when gestational age is between 24 and 34 weeks to allow time for administration of corticosteroids to enhance fetal lung maturity and/or transport the mother to a facility with neonatal intensive care capabilities.

Key Points

  • Tocolytics do not stop preterm labor permanently; they typically delay delivery by 48-72 hours.
  • The goal is to gain time for corticosteroid administration for fetal lung maturity.

Classes of Tocolytic Medications

Beta-Adrenergic Agonists

  • Terbutaline: A beta-mimetic that relaxes smooth muscle in the uterus by stimulating beta-2 adrenergic receptors, causing decreased intracellular calcium and reduced myometrial contractility. Typically administered subcutaneously at 0.25 mg every 3-4 hours.
  • Ritodrine: Though less commonly used now, it works similarly to terbutaline by stimulating beta-2 receptors to inhibit uterine contractions.

Key Points

  • Beta-adrenergic agonists have significant maternal side effects including tachycardia, pulmonary edema, and hyperglycemia.
  • Continuous cardiac monitoring is essential during administration.
Beta-agonists are contraindicated in women with cardiac disease, uncontrolled diabetes, hyperthyroidism, and pulmonary hypertension.

Calcium Channel Blockers

  • Nifedipine: Inhibits calcium influx across cell membranes, preventing the calcium-dependent myometrial contractions. Typically administered as 10-20 mg orally every 4-6 hours.

Key Points

  • Nifedipine has fewer maternal side effects than beta-agonists and is often considered first-line therapy.
  • Monitor blood pressure closely as hypotension is a common side effect.
Never administer nifedipine sublingually for tocolysis due to risk of severe hypotension.

Magnesium Sulfate

  • Acts as a calcium antagonist to decrease myometrial contractility. Administered intravenously with a loading dose of 4-6 g over 20-30 minutes, followed by maintenance infusion of 2-3 g/hour.

Key Points

  • Magnesium sulfate crosses the placenta and may cause respiratory depression in the neonate if delivery occurs during treatment.
  • Also provides neuroprotection for fetuses less than 32 weeks gestation.
Monitor respiratory rate, deep tendon reflexes, urinary output, and magnesium levels to prevent toxicity. Keep calcium gluconate readily available as the antidote.

Prostaglandin Inhibitors

  • Indomethacin: A non-steroidal anti-inflammatory drug (NSAID) that inhibits prostaglandin synthesis, reducing uterine contractions. Initial dose is 50-100 mg orally or rectally, followed by 25-50 mg every 6 hours for up to 48 hours.

Key Points

  • Limited to use before 32 weeks gestation due to fetal risks.
  • May cause premature closure of the ductus arteriosus and oligohydramnios with prolonged use.
Limit use to 48-72 hours and monitor amniotic fluid volume and fetal ductal flow if possible.

Oxytocin Receptor Antagonists

  • Atosiban: Competitively blocks oxytocin receptors in the myometrium, preventing oxytocin-induced contractions. Not available in the United States but used in other countries.

Key Points

  • Has fewer cardiovascular side effects than beta-agonists.
  • Administered as IV infusion with loading dose followed by maintenance therapy.

Administration and Nursing Considerations

Nursing Assessment Before Tocolytic Therapy

  1. Confirm gestational age (typically between 24-34 weeks)
  2. Assess maternal vital signs, especially cardiac and respiratory status
  3. Evaluate fetal heart rate and pattern
  4. Confirm absence of contraindications to tocolysis
  5. Assess cervical dilation and effacement

Key Points

  • Tocolytics are generally not effective if cervical dilation exceeds 4 cm.
  • Always verify that there are no contraindications to delayed delivery.

Contraindications to Tocolytic Therapy

  • Absolute contraindications include severe preeclampsia, eclampsia, maternal hemorrhage, chorioamnionitis, fetal demise, fetal anomalies incompatible with life, mature fetal lung studies, and advanced cervical dilation.
  • Relative contraindications include mild preeclampsia, controlled maternal hypertension, prior uterine surgery, mild vaginal bleeding, and intrauterine growth restriction.

Key Points

  • The risks of continuing pregnancy must be weighed against the benefits of delaying delivery.
  • Each tocolytic also has specific contraindications based on its mechanism of action.

Monitoring During Tocolytic Administration

  • Continuous fetal monitoring to assess fetal heart rate and pattern
  • Maternal vital signs, including cardiac monitoring with beta-agonists
  • Uterine contraction frequency, duration, and intensity
  • Medication-specific monitoring (e.g., deep tendon reflexes for magnesium sulfate)

Clinical Scenario: A 28-year-old G2P1 at 29 weeks gestation presents with regular contractions every 5 minutes. After assessment confirms preterm labor with cervical changes (2 cm dilated, 50% effaced), magnesium sulfate tocolysis is initiated. The nurse must monitor respiratory rate, deep tendon reflexes, and urinary output hourly, maintain IV rate precisely, assess for signs of magnesium toxicity, and prepare for potential administration of corticosteroids for fetal lung maturity.

Commonly Confused Points

Tocolytics vs. Tocodynamometer

Tocolytics Tocodynamometer
Medications that inhibit uterine contractions Device used to monitor uterine contractions
Therapeutic intervention to delay preterm birth Diagnostic tool for assessing contraction patterns
Examples: nifedipine, terbutaline, magnesium sulfate External monitor placed on maternal abdomen

Magnesium Sulfate: Tocolytic vs. Seizure Prophylaxis

Magnesium Sulfate as Tocolytic Magnesium Sulfate for Preeclampsia
Used to inhibit preterm labor Used to prevent seizures in preeclampsia
Dosage: 4-6g loading dose, 2-3g/hr maintenance Dosage: 4-6g loading dose, 1-2g/hr maintenance
Goal: Delay delivery by 48-72 hours Goal: Prevent eclamptic seizures
Contraindicated in severe preeclampsia Standard treatment for severe preeclampsia

Key Points

  • The same medication (magnesium sulfate) is used for different purposes with similar but distinct dosing protocols.
  • Monitoring parameters are the same for both uses: respiratory rate, deep tendon reflexes, and urinary output.

Beta-agonists vs. Calcium Channel Blockers

Beta-agonists (Terbutaline) Calcium Channel Blockers (Nifedipine)
Administration: Subcutaneous or IV Administration: Oral
Side effects: Tachycardia, palpitations, tremors, pulmonary edema Side effects: Hypotension, headache, dizziness
Requires continuous cardiac monitoring Requires regular blood pressure monitoring
More significant maternal side effects Generally better tolerated

Study Tips and Memory Aids

Remembering Tocolytic Classes

TOCO-BLOCK Memory Aid

  • T - Terbutaline (Beta-agonist)
  • O - Oxytocin antagonists (Atosiban)
  • C - Calcium channel blockers (Nifedipine)
  • O - Off-label NSAIDs (Indomethacin)
  • B - Beta-mimetics (Terbutaline, Ritodrine)
  • L - Labor inhibitors all have specific risks
  • O - Only temporary effect (48-72 hours)
  • C - Calcium antagonist (Magnesium Sulfate)
  • K - Keep monitoring mother and fetus closely

Monitoring Magnesium Toxicity

REFLEXES Memory Aid for Magnesium Monitoring

  • R - Respiratory depression (< 12 breaths/min)
  • E - Evaluate deep tendon reflexes (loss = toxicity)
  • F - Fluid balance (urinary output < 30 mL/hr concerning)
  • L - Levels of magnesium (therapeutic: 4-7 mEq/L)
  • E - Emergency calcium gluconate as antidote
  • X - X-out high doses if symptoms appear
  • E - Evaluate vital signs frequently
  • S - Serum levels guide therapy

Common Pitfalls in Tocolytic Therapy

Common Pitfalls:

  • Using tocolytics when contraindicated (e.g., chorioamnionitis, severe preeclampsia)
  • Administering multiple tocolytics simultaneously (increases risk of serious side effects)
  • Continuing tocolysis beyond 48-72 hours without clear indication
  • Failing to administer corticosteroids during the window provided by tocolysis
  • Inadequate monitoring of maternal-fetal status during tocolytic administration

Quick Self-Assessment

Quick Check

  1. What is the primary goal of tocolytic therapy?
  2. Name three classes of tocolytic medications.
  3. What are the signs of magnesium toxicity?
  4. What medication is the antidote for magnesium toxicity?
  5. What are the absolute contraindications to tocolytic therapy?

Summary of Key Points

  • Purpose: Tocolytics delay preterm labor for 48-72 hours to allow for corticosteroid administration and/or maternal transport.
  • Major Classes: Beta-agonists, calcium channel blockers, magnesium sulfate, prostaglandin inhibitors, and oxytocin antagonists.
  • First-line Agents: Nifedipine and magnesium sulfate are often preferred due to better side effect profiles.
  • Monitoring: Each tocolytic requires specific maternal and fetal monitoring parameters based on its mechanism of action and side effect profile.
  • Contraindications: Tocolytics should not be used in cases of severe preeclampsia, chorioamnionitis, significant hemorrhage, or when delivery is beneficial to mother or fetus.
  • Dual Purpose: Magnesium sulfate serves as both a tocolytic and neuroprotective agent for fetuses less than 32 weeks gestation.

Remember that understanding tocolytic medications is crucial for safe maternity nursing practice. These medications require careful assessment, administration, and monitoring. Your knowledge in this area directly impacts the safety of both mother and baby during a critical situation. Stay confident and focused on mastering these concepts for the NCLEX and your future nursing practice!

다음 이론을 계속 학습하려면 로그인하세요.

로그인하고 계속 학습
컨텐츠를 그만볼래?

필기노트, 하이라이터, 메모는 잘 쓰고 있어?

내보내줘
어떤 폴더에 저장할래?

컨텐츠 노트에는 총 0개의 폴더가 있어!

폴더 만들기
컨텐츠 만들기
만들기
신고했어요.

운영진이 검토할게요!

해당 유저를 차단했어요.

마이페이지에서 차단한 회원을 관리할 수 있어요.